Abstract
Background
Delayed cerebral ischemia increases mortality and morbidity after aneurysmal subarachnoid hemorrhage (aSAH). Various techniques are applied to detect cerebral vasospasm and hypoperfusion. Contrast-enhanced ultrasound perfusion imaging (UPI) is able to detect cerebral hypoperfusion in acute ischemic stroke. This prospective study aimed to evaluate the use of UPI to enable detection of cerebral hypoperfusion after aSAH.
Methods
We prospectively enrolled patients with aSAH and performed UPI examinations every second day after aneurysm closure. Perfusion of the basal ganglia was outlined to normalize the perfusion records of the anterior and posterior middle cerebral artery territory. We applied various models to characterize longitudinal perfusion alterations in patients with delayed ischemic neurologic deficit (DIND) across the cohort and predict DIND by using a multilayer classification model.
Results
Between August 2013 and December 2015, we included 30 patients into this prospective study. The left–right difference of time to peak (TTP) values showed a significant increase at day 10–12. Patients with DIND demonstrated a significant, 4.86 times increase of the left–right TTP ratio compared with a mean fold change in patients without DIND of 0.9 times (p = 0.032).
Conclusions
UPI is feasible to enable detection of cerebral tissue hypoperfusion after aSAH, and the left–right difference of TTP values is the most indicative result of this finding.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Delayed cerebral ischemia (DCI) due to hypoperfusion in the course of cerebral vasospasm is, besides rebleeding, the leading cause of morbidity and mortality after initial aneurysmal rupture in subarachnoid hemorrhage (SAH) [1, 2]. Approximately 30% of patients with aneurysmal SAH (aSAH) develop DCI [3]. The pathogenesis of DCI is not fully attributable to large-vessel vasospasm alone, but rather hemodynamic alterations (e.g., impaired cerebral perfusion due to different mechanisms) is the common denominator [4, 5]. Because DCI is preceded by an impaired cerebral perfusion, using a noninvasive screening tool that measures cerebral perfusion to enable the detection of disturbances of the cerebral microcirculation rather than a surrogate parameter, such as blood flow velocities within the cerebral vessels, might be superior [6,7,8].
Recently, a proof-of-concept study showed the capability of cerebral ultrasound perfusion imaging (UPI) to determine normoperfused, hypoperfused, and nonperfused tissue in patients with acute ischemic stroke [9, 10]. UPI might be a useful screening tool in patients with SAH to assess cerebral perfusion. We performed this prospective study to evaluate the capability of contrast-enhanced UPI to enable the detection of cerebral hypoperfusion in patients with SAH.
Methods
Population and Study Design
We prospectively included patients with aSAH who were admitted to the Department of Neurosurgery at the University Hospital Bern between August 2013 and December 2015. Inclusion criteria were as follows: confirmed aSAH, admission within 72 h after SAH, 18 years of age or older, and written informed consent. Patients were excluded in cases of pregnancy, severe heart and lung disease, allergy to SonoVue, and severe renal insufficiency. The results of the perfusion measurement served as the primary end point. All patients were treated according to institutional protocols and international guidelines [11, 12], including aneurysm occlusion within 24 h after admission and administration of oral nimodipine. Initial UPI was performed (see UPI protocol as follows) after aneurysm occlusion and within 4 days after admission, and thereafter every second day during the 14-day period after ictus. A clinical assessment for the presence of a delayed ischemic neurologic deficit (DIND) was done prior to UPI measurement by the treating medical staff. The study was approved by the local ethics committee (Kantonale Ethikkommission Bern 174/12) and has been registered (identifier: NCT02907879). Informed consent was obtained from patients or next of kin.
DIND
Delayed ischemic neurological deficit was defined as the occurrence of focal neurological impairment, such as hemiparesis, aphasia, apraxia, hemianopia, or neglect, or a decrease of at least 2 points on the Glasgow Coma Scale for at least 1 h that cannot be attributed to other causes by means of clinical assessment, computed tomography (CT), or magnetic resonance imaging of the brain and appropriate laboratory studies [13]. We used DIND as an outcome parameter rather than DCI because the rationale of UPI is to assess hypoperfusion to prevent cerebral ischemia.
UPI
Ultrasound perfusion imaging was performed by a dedicated study team who were not masked for clinical course. The transcranial color duplex sonography was performed with a 1–5 MHz dynamic sector array (S5-1) from a Philips iU22 ultrasound machine (Philips Healthcare, Andover, MA). The field-of-view was set to an imaging depth of 150 mm in a sector angle of 90°. The imaging plane was then tilted to the diencephalic plane as described before, in which the frontal horns of the side ventricles and the third ventricle serve as landmarks and where the anterior and posterior middle cerebral artery (MCA) territory and the basal ganglia (BG) as region of interest could be identified without artifacts from major vessels [14]. High mechanical index bolus imaging was performed from both sides individually [14]. Data acquisition of 45 s was started immediately after intravenous (i.v.) injection of a 2-ml bolus of the second-generation contrast enhancer SonoVue (Bracco International, Milano, Italy), followed by a 10-ml flush of saline using an mechanical index (MI) setting of 1.34 and a frame rate of 5 Hz.
Postprocessing Image Data of UPI
UPI data were analyzed offline by using VueBox 4.3 (Bracco Imaging, Geneva, Switzerland). A complete examination consisted of two single UPI examinations, one performed from the left side and one performed from the right side. Time to peak (TTP) and mean transit time (MTT) were quantified in four regions of interest (ROIs) per UPI examination: BG of the ipsilateral and contralateral hemisphere and anterior and posterior MCA territory of the contralateral hemisphere. Therefore, a complete examination resulted in eight ROIs to be analyzed (Fig. 1a).
Analysis of the CT Perfusion Measurements
From CT perfusion (Siemens Somatom Edge, Nürnberg, Germany), we measured the TTP and MTT of all segmented anatomic regions of 16 patients, namely the MCA and BG (OLEA Medical, France). We normalized the MCA against the BG regions, similar to UPI normalization (see “Normalization of UPI” section). All further analyses comparing CT TTP and MTT with UPI values were performed in concomitance with the analyses of UPI values. Detailed information is provided in the statistical methods section.
Statistical Analysis
Normalization of UPI
The difference between left and right BG regions was performed by a linear regression model; significance was determined by Pearson’s product moment correlation coefficient. Further normalization of MCA regions (PMCA) was performed by relative scaling of the measurements in accordance with the BG perfusion (PBG).
P, perfusion measurements; n, number of BG perfusion measurements; z, number of MCA perfusion measurements.
Ratios of Baseline-Follow-Up Measurements
To calculate the difference between baseline perfusion (day 1–3) and later time points, we used the fold change (PT1,T2,…Tn/Pbaseline) to evaluate perfusion restriction. The Wilcoxon rank sum test was used to determine significance, and p value adjustment was performed by Benjamini-Hochberg.
Tracking Therapeutic Intervention
Because UPI has not been validated as a tool for predicting cerebral tissue hypoperfusion and a gold standard for verifying tissue hypoperfusion has not been defined, we aimed to semiquantitatively assess tissue perfusion by comparing TTP values before and after spasmolysis (intraarterial injection of nimodipine).
Prediction Model
To achieve a simple structuring of the information, we decided to implement a decision tree model with hierarchically structured information that passes through three filter layers to determine between high-risk and moderate-risk UPI examinations. We trained the decision tree using squared error as the cost function to estimate the split point within each layer. In the first layer, we evaluated the intraside difference between the anterior and posterior ROIs. The following layers two and three evaluate the perfusion ratios between the left and right MCA territory.
nP defined the normalized TTP measurements of the defined ROIs.
In case a UPI examination showed ratios above at least one of the trained thresholds (layer 1 > factor 1.48, layer 2 > 2.1, layer 3 > 1.3), the examination was ranked as high-risk. In cases in which no ratios were found that defined patients as being high-risk, the examination was ranked as moderate-risk. The thresholds were tailored to high sensitivity of the model by accepting a high rate of false positive UPI measurements.
Results
Between August 2013 and December 2015, we enrolled 30 patients into this prospective study. Twenty-four patients (80%) were women and six patients were men (20%). The median age was 54 years (interquartile range 48–67). In 28 patients (93%), the ruptured aneurysm was treated by endovascular coiling, and two patients underwent clipping. Twelve (40%) patients presented with a DIND. For further analyses of the UPI, we defined the minimum requirements of sequential examinations as follows: a baseline UPI examination (at day 1–3) and two follow-up UPI measurements at a median time point of 4–12 days and a late time point at 13–21 days. Of 30 patients, 27 met the inclusion criteria for sufficient follow-up (total of 130 UPI examinations), and the number of examinations per patient ranged from 3 to 9 examinations (Fig. 1a).
Perfusion Midline Region Measurements Normalize Interpatient Variance
First, we benchmarked the robustness of the various UPI parameters across patients and measurements, which uncovered a strong interpatient and intrapatient variance of MTT and TTP values (Fig. 2a–d). To normalize multiple measurements, we used a relatively stable quotient of the right and left perfusion at the midline region ROI (Fig. 1b). Across all examinations, a strong correlation of the midline region ROI was found (R2 = 0.72, p < 0.001) for the TTP measurements but not for the MTT measurements (Fig. 1c–d). Based on the fact that MTT measurements revealed considerably more susceptible to disturbances during normalization and did not show robust measurements within multiple examinations we focused on TTP measurements in the further analysis. In the following sections, we refer to TTP as normalized TTP values.
Tracking Therapeutic Intervention Prespasmolysis and Postspasmolysis
In Fig. 3, we present serial TTP measurements, including measurements before and after spasmolysis at day 10. In the cohort, four patients underwent a spasmolysis. All these patients showed a significant reduction of the TTP measurements (9.62-s delay vs. 6.07-s delay, p = 0.043) comparing prespasmolysis with postspasmolysis (Fig. 3a). Our data confirmed that normalized TTP values were more robust in tracking the effects of spasmolysis across multiple examinations (Fig. 3b).
Normalization of MCA Territory and Longitudinal Observation
We assumed that vasospasm dominantly affect one MCA territory, which leads to interference within the regional examination areas of the left and right hemispheres. To investigate the extent to which perfusion measurements are influenced by this circumstance, we analyzed the ratios of left-to-right TTP values. In patients with DIND, we detected a significant change between left-to-right TTP ratios, particularly at the critical time frame between days 7–12. Patients with DIND showed a significant, 4.86 times increase of the left/right TTP ratio compared to a mean fold change in patients without DIND of 0.9 times (p = 0.032, Figs. 4a, 5).
Comparison Between CT Perfusion and UPI
In order to validate our data by the most broadly used imaging method to quantify cerebral perfusion, we compared CT perfusion at early (3 days) and late timepoints (8–12 days) with paired UPI measurements. Paired CT and UPI data were available for 16 patients with highly significant correlation between right and left midbrain regions (R 0.92, p < 0.001) confirming the accuracy of UPI-TTP measurements. From comparing the left-to-right ratio (p = 0.2) or longitudinal development of TTP changes, we did not observe significant differences in neither MTT nor TTP perfusion from CT imaging (Fig. 6).
Results of UPI in Symptomatic Patients
On longitudinal measurements of the left–right difference (LRDiff) of TTP comparing patients with DIND (red) attributable to cerebral hypoperfusion with those without DIND (green), LRDiff shows a significantly increase in patients with a DIND, with a peak at days 10–12 (p = 0.032) (see Fig. 4b).
Even though there is a pronounced variance of UPI measurements of the cohort, the parameter LRDiff showed a robust differentiation between affected patients and nonaffected patients.
Prediction Model for DIND Based on UPI Records
Although LRDiff of TTP was found to predict tissue hypoperfusion, the overall accuracy was limited because of a pronounced heterogeneity within the cohort. Our data suggest that single parameters of UPI may allow a prediction of tissue hypoperfusion leading to DIND. To improve the accuracy of our UPI-based prediction of DIND, a multilayer prediction model was designed in which each UPI examination was evaluated at multiple levels and rated based on the estimated risk of DIND. We decided to evaluate single UPI examinations and not stratify patients in our prediction model because patients with DIND revealed nonpathological perfusion at baseline examinations.
We established a decision tree model to select patients at risk for DIND (Fig. 7, Table 1). To be classified as high-risk, a UPI examination must have met at least one of the following criteria. At the first layer, we estimated the difference between anterior and posterior TTP measurements (intraside TTP difference). UPI examinations (n = 127) with a ratio between anterior and posterior TTP values more than 1.48 were found to be at risk for DIND, with an accuracy of 55.9% (sensitivity 37.7% and specificity 94.4%). In the second layer UPI examinations that passed the first layer (n = 104) were evaluated based on the above explained left-to-right TTP ratio (interside difference). Ratios of the difference in mean higher than 2.1 were found to be highly associated with DIND (accuracy 75%, sensitivity 56%, and specificity 98%). In the third layer, examinations that passed the first two layers (n = 74) were evaluated based on the left-to-right difference of the minimal TTP values within all examined regions. If the ratio between left and right was higher than 1.11, the UPI examination was ranked as high-risk (accuracy 91.89%, sensitivity 79%, and specificity 98%). The model was tailored to minimize the number of false negative evaluations. In our cohort, the global accuracy of our decision model was 92%, with a sensitivity of 93.15% and a specificity of 90.7% (Fisher’s exact test, p < 2.2 × 10−16. Examples of patients are given in Fig. 8.
Discussion
This is the first prospective study evaluating the capability of UPI to detect cerebral hypoperfusion in the setting of aSAH. The results of this first study are threefold. First, we could show that there is a strong correlation of the midline ROIs for the TTP examination and that these measurements can be used to normalize the ROIs of the MCA territory. This normalization is necessary because of the high variance of raw signals and leads to a reduction of unspecific bias of individual measurements. In aSAH perfusion restrictions of the midline regions are conceivable and insufficiently investigated. Up to date most studies have been performed in patients with ischemic stroke [15,16,17]. Secondly, the data show that the LRDiff of the minimal obtained perfusion does most likely predict a cerebral hypoperfusion. Lastly, we could present a three-layer prediction model for cerebral hypoperfusion based on these first results.
In assessable patients, the clinical examination is the mainstay of diagnosing DIND. Yet, patients with aSAH are often severely impaired or even sedated, intubated, and clinical examination is of limited use. Additional examinations are used to diagnose possible vasospasms. Transcranial doppler sonography (TCD) is the mainstay in bedside detection of cerebral vasospasm [11, 12]. Despite its wide use, it has important drawbacks. There is a lack of evidence of the usefulness of TCD and only low or very high mean MCA flow velocities (i.e., < 120 or ≥ 200 cm/s) reliably predicted the absence or presence of clinically significant angiographic vasospasm [18, 19]. In addition, assessment of TCD is observer-dependent, requires regular practice, and depends on an adequate acoustic bone window [20, 21]. TCD only measures the surrogate parameter, flow velocity, and no tissue perfusion. Compared with UPI assessments, TCD and UPI share some drawbacks. In this investigation, we have only assessed the MCA territory, and a UPI examination also requires a learning curve and is, to some part, observer-dependent. UPI measurements has some advantage in patients with inadequate temporal bone window, because the application of i.v. contrast enables examinations when conventional TCD examinations fail. Yet, the main advantage is the evaluation of tissue perfusion rather than a surrogate parameter. Other methods such as CT perfusion (CTP) or magnetic resonance tomography perfusion can assess relative tissue perfusion [22] but pose additional risks to the patient. Mainly transport of the intensive care patient, flat body position in patients with critical intracranial pressure elevation, x-ray exposure, intolerances and additional high costs. UPI can avoid some of these risks because the examination can be performed in the intensive care unit and on patients in different body positions. It does not require x-ray or additional resources, such as scanning time, and is therefore in any order repeatable. For long, arterial narrowing on digital subtraction angiography was the accepted gold standard for arterial vasospasm. Despite a correlation between arterial diameter and proximal cerebral circulation time (distal internal carotid artery and M4 segment of the MCA), this could also not be proven for arterial diameter and parenchymal cerebral circulation time [23]. In addition, arterial narrowing on digital subtraction angiography (DSA) does not always correlate with DIND or DCI [24, 25]. Therefore DSA, seems to display proximal arterial narrowing yet adds limited value to the diagnosis of peripheral vasospasm and actual tissue perfusion.
The aforementioned techniques to detect cerebral vasospasm and hypoperfusion in the setting of SAH have been evaluated in various studies including systematic reviews. Compared to our decision model (sensitivity 93.15%, specificity 90.7%) the sensitivities and specificities are reported to be 90% and 71% for TCD [26], 79.6% and 93.1% for CTA [27], and 74.1% and 93% for CTP [27]. Data on sensitivity and specificity for perfusion weighted magnetic resonance imaging are not available. In addition, many studies indicate DSA as being the gold standard for detection of cerebral vasospasm, therefore yielding no data either. The limitation of the current literature is that with respect to TCD the single studies have defined different cutoff values for cerebral vasospasm [26], for CTP studies different perfusion parameters and different thresholds are reported to have the highest diagnostic yield [28, 29] and in general the definition of cerebral vasospasm is far from uniform [26].
Our proposed decision tree should be regarded as a first approach to sort out patients who are at risk. Because of the limited amount of included UPI measurements this decision tree should not be regarded as final.
An optimal screening tool for patients with aSAH to prevent DCI would be capable to assess tissue perfusion, be performed bedside, be repeatable, without additional x-ray exposure, and low costs. In this first prospective study, we could show that UPI meets these requirements. Despite this first encouraging results this methods needs further investigation in larger prospective trials.
The limitations of this study are its single center design and the limited number of included patients. The study team performing the UPI examinations was not blinded for clinical course. In addition, DIND is a subjective outcome measure and was only present in 12 out of 27 patients, which might introduce a bias.
Conclusions
In conclusion, the assessment of UPI to enable detection of cerebral hypoperfusion after aSAH is feasible. What is most indicative of this is the left–right difference of TTP values. We propose a multilayer model to define patients at a high risk for cerebral hypoperfusion. Further prospective studies are required prior to routine clinical use of UPI measurements to detect cerebral hypoperfusion in patients with SAH.
References
Kassell NF, Torner JC, Haley EC Jr, et al. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg. 1990;73(1):18–36.
Dorhout Mees SM, Kerr RS, Rinkel GJ, Algra A, Molyneux AJ. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the international subarachnoid aneurysm trial (ISAT). J Neurol. 2012;259(4):679–83.
Roos YB, de Haan RJ, Beenen LF, et al. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry. 2000;68(3):337–41.
Mir DI, Gupta A, Dunning A, et al. CT perfusion for detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2014;35(5):866–71.
Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci. 2007;28(6):252–6.
Dankbaar JW, Rijsdijk M, van der Schaaf IC, et al. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51(12):813–9.
Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 2005;56(4):633–54 (discussion 54).
Pham M, Johnson A, Bartsch AJ, et al. CT perfusion predicts secondary cerebral infarction after aneurysmal subarachnoid hemorrhage. Neurology. 2007;69(8):762–5.
Reitmeir R, Eyding J, Oertel MF, et al. Is ultrasound perfusion imaging capable of detecting mismatch? A proof-of-concept study in acute stroke patients. J Cereb Blood Flow Metab. 2017;37(4):1517–26.
Eyding J, Reitmeir R, Oertel M, et al. Ultrasonic quantification of cerebral perfusion in acute anterior circulation occlusive stroke-a comparative challenge of the refill- and the bolus-kinetics approach. PLoS ONE. 2019;14(8):e0220171.
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–37.
Diringer MN, Bleck TP, Claude Hemphill J 3rd, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–5.
Eyding J, Nolte-Martin A, Krogias C, Postert T. Changes of contrast-specific ultrasonic cerebral perfusion patterns in the course of stroke; reliability of region-wise and parametric imaging analysis. Ultrasound Med Biol. 2007;33(3):329–34.
Postert T, Muhs A, Meves S, et al. Transient response harmonic imaging: an ultrasound technique related to brain perfusion. Stroke. 1998;29(9):1901–7.
Postert T, Federlein J, Weber S, Przuntek H, Büttner T. Second harmonic imaging in acute middle cerebral artery infarction. Preliminary Results Stroke. 1999;30(8):1702–6.
Federlein J, Postert T, Meves S, et al. Ultrasonic evaluation of pathological brain perfusion in acute stroke using second harmonic imaging. J Neurol Neurosurg Psychiatry. 2000;69(5):616–22.
Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1999;44(6):1237–47 (discussion 47–8).
Mastantuono JM, Combescure C, Elia N, Tramèr MR, Lysakowski C. Transcranial Doppler in the diagnosis of cerebral vasospasm: an updated meta-analysis. Crit Care Med. 2018;46(10):1665–72.
Sharma S, Lubrica RJ, Song M, et al. The role of transcranial Doppler in cerebral vasospasm: a literature review. Acta Neurochir Suppl. 2020;127:201–5.
Shen Q, Stuart J, Venkatesh B, Wallace J, Lipman J. Inter observer variability of the transcranial Doppler ultrasound technique: impact of lack of practice on the accuracy of measurement. J Clin Monit Comput. 1999;15(3–4):179–84.
Beck J, Raabe A, Lanfermann H, Seifert V, Weidauer S. Tissue at risk concept for endovascular treatment of severe vasospasm after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004;75(12):1779–81.
Ohkuma H, Ogane K, Tanaka M, Suzuki S. Assessment of cerebral microcirculatory changes during cerebral vasospasm by analyzing cerebral circulation time on DSA images. Acta Neurochir Suppl. 2001;77:127–30.
Stein SC, Levine JM, Nagpal S, LeRoux PD. Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus. 2006;21(3):E2.
Nolan CP, Macdonald RL. Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus. 2006;21(3):E1.
Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124(5):1257–64.
Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis. AJNR Am J Neuroradiol. 2010;31(10):1853–60.
Vulcu S, Wagner F, Santos AF, et al. Repetitive computed tomography perfusion for detection of cerebral vasospasm-related hypoperfusion in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;121:e739–46.
Sanelli PC, Ugorec I, Johnson CE, et al. Using quantitative CT perfusion for evaluation of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2011;32(11):2047–53.
Funding
Open Access funding enabled and organized by Projekt DEAL. This study was funded by the Swiss National Science Foundation (320030_135477/1).
Author information
Authors and Affiliations
Contributions
Conception and design of the study: JB, WJZ, AR, and JE. Acquisition and analysis of data: CF, DHH, and RR. Drafting a significant portion of the article or figures: CF, DHH, WDN, RR, OS, and JB. The final manuscript was approved by all authors.
Corresponding author
Ethics declarations
Conflicts of Interest
The authors report no conflict of interests.
Ethical approval
The study reported here adheres to ethical guidelines. Approval was obtained from the local ethics committee (Kantonale Ethikkommission, Bern, Switzerland, KEK ID 019/10) and Swissmedic (Bern, Switzerland, ID 2012 DR 2135), and the study conformed to the Declaration of Helsinki.
Clinical Trial registration
ClinicalTrials.gov: NCT02907879.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fung, C., Heiland, D.H., Reitmeir, R. et al. Ultrasound Perfusion Imaging for the Detection of Cerebral Hypoperfusion After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 37, 149–159 (2022). https://doi.org/10.1007/s12028-022-01460-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-022-01460-z